VRSK:NASDAQVerisk Analytics, Inc. Analysis
Data as of 2026-05-27 - not real-time
$171.50
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Verisk Analytics is trading around $171.5, which sits below its 20‑day SMA (~$172) and well under the 50‑day (~$179) and 200‑day (~$215) averages, confirming a bearish price trend. The RSI at the mid‑40s signals neutral momentum, while the MACD line has crossed above its signal line, generating a bullish histogram that suggests a short‑term bounce may be possible. However, a 30‑day volatility of roughly 39% and a computed beta near -0.13 highlight heightened price swings and a weak correlation to the broader market, raising the overall risk profile. The DCF fair‑value estimate of about $80.8 is dramatically lower than the current market price, implying the stock is substantially overvalued relative to intrinsic fundamentals.
On the fundamentals side, Verisk delivers exceptional profitability with a gross margin near 70% and operating margin above 45%, while revenue is growing modestly at ~4% annually. Free cash flow exceeds $940 million and the dividend yield of 1.17% is supported by a payout ratio under 30%, indicating dividend sustainability. Recent product announcements—including the Model Context Protocol for conversational AI and expanded catastrophe‑risk model access—could unlock new revenue streams, and analyst consensus remains a “Buy” with a mean target near $220, suggesting upside potential if valuation compresses.
On the fundamentals side, Verisk delivers exceptional profitability with a gross margin near 70% and operating margin above 45%, while revenue is growing modestly at ~4% annually. Free cash flow exceeds $940 million and the dividend yield of 1.17% is supported by a payout ratio under 30%, indicating dividend sustainability. Recent product announcements—including the Model Context Protocol for conversational AI and expanded catastrophe‑risk model access—could unlock new revenue streams, and analyst consensus remains a “Buy” with a mean target near $220, suggesting upside potential if valuation compresses.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD histogram suggests a potential near‑term bounce
- Price is near the identified support level
- High short‑term volatility could cause rapid swings
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong profit margins and growing free cash flow
- Modest revenue growth paired with recurring subscription models
- Analyst target median price around $220 indicating upside if valuation narrows
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Sustainable dividend with low payout ratio
- Strategic AI‑driven product launches expanding addressable market
- Resilient business model serving the insurance industry with high barriers to entry
Key Metrics & Analysis
Financial Health
Revenue Growth3.90%
Profit Margin29.34%
P/E Ratio26.1
ROA18.00%
P/B Ratio76.8
Op. Cash Flow$1.4B
Free Cash Flow$944.4M
Industry P/E30.1
Technical Analysis
TrendBearish
RSI47.6
Support$155.94
Resistance$191.51
MA 20$172.24
MA 50$178.88
MA 200$215.09
MACDBullish
VolumeStable
Fear & Greed Index92.34
Valuation
Fair Value$80.76
Target Price$220.47
Upside/Downside28.55%
GradeOvervalued
TypeGrowth
Dividend Yield1.17%
Risk Assessment
Beta-0.13
Volatility39.05%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.